Últimas
Grünenthal's Glucocorticoid Receptor Modulator enters clinical development
The Phase I trial includes 80 healthy volunteers and is designed as a head to head comparison between the GRM and prednisolone, the most frequently used glucocorticoid.[1] Observing several…